 |
 |

Chronic Parkinsonism Associated With Cirrhosis
A Distinct Subset of Acquired Hepatocerebral Degeneration
Pierre R. Burkhard, MD;
Jacqueline Delavelle, MD;
Renaud Du Pasquier, MD;
Laurent Spahr, MD
Arch Neurol. 2003;60:521-528.
Context The clinical, neuroradiological, and biological characteristics of the so-called acquired hepatocerebral degeneration have not yet been fully determined and its frequency remains largely uncertain.
Objectives To prospectively study the prevalence of extrapyramidal symptoms in patients with moderate to severe cirrhosis of various causes, to delineate the main neurological features of the condition, and to establish correlations with neuroradiological and biological findings.
Patients and Methods During a 1-year period, all consecutive patients with cirrhosis who were potential candidates for liver transplantation were screened for extrapyramidal features. When extrapyramidal features were present, further workup included a detailed neurological examination, magnetic resonance imaging of the brain, a comprehensive battery of neuropsychological tests, extensive blood tests, and, in some cases, cerebrospinal fluid analysis.
Setting A community-based hospital.
Results From 51 patients screened, 11 (21.6%) exhibited moderate to severe parkinsonism sometimes associated with focal dystonia. Typical features included rapid progression over months, symmetric akinetic-rigid syndrome, postural but not resting tremor, and early postural and gait impairment. Neuropsychiatric manifestations were minimal. Some patients were responsive to levodopa therapy. In all patients, magnetic resonance imaging scans showed striking hyperintensities on T1-weighted images typically involving the substantia nigra and the globus pallidus bilaterally. Whole blood and cerebrospinal fluid manganese concentrations were severalfold above the reference range.
Conclusions Cirrhosis-related parkinsonism may represent a unique, consistent, and common subset of acquired hepatocerebral degeneration, whose features are permanent and entirely different from acute hepatic encephalopathy episodes. This form of parkinsonism can be clearly distinguished from other forms of parkinsonism of middle to advanced age, based on a suggestive association of clinical, neuroradiological, and biological abnormalities. Our findings support the concept of the toxic effects of manganese being the major determinant of basal ganglia dysfunction leading to the predominantly extrapyramidal central nervous system manifestations of cirrhosis observed in these patients.
From the Departments of Neurology (Drs Burkhard and Du Pasquier), Neuroradiology (Dr Delavelle), and Gastroenterology and Hepatology (Dr Spahr), University Hospital, Geneva, Switzerland.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese
Stepens et al.
NEJM 2008;358:1009-1017.
ABSTRACT
| FULL TEXT
Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity
Klos et al.
Neurology 2006;67:1984-1989.
ABSTRACT
| FULL TEXT
Evidence for Cortical Dysfunction and Widespread Manganese Accumulation in the Nonhuman Primate Brain following Chronic Manganese Exposure: A 1H-MRS and MRI Study
Guilarte et al.
Toxicol Sci 2006;94:351-358.
ABSTRACT
| FULL TEXT
Occupational manganese neurotoxicity provoked by hepatitis C.
Schaumburg et al.
Neurology 2006;67:322-323.
ABSTRACT
| FULL TEXT
An Overview of Psychiatric Issues in Liver Disease for the Consultation-Liaison Psychiatrist
Crone et al.
Psychosomatics 2006;47:188-205.
ABSTRACT
| FULL TEXT
Neurologic Spectrum of Chronic Liver Failure and Basal Ganglia T1 Hyperintensity on Magnetic Resonance Imaging: Probable Manganese Neurotoxicity
Klos et al.
Arch Neurol 2005;62:1385-1390.
ABSTRACT
| FULL TEXT
Searching for a relationship between manganese and welding and Parkinson's disease
Jankovic
Neurology 2005;64:2021-2028.
ABSTRACT
| FULL TEXT
A Novel Isoform of the Secretory Pathway Ca2+,Mn2+-ATPase, hSPCA2, Has Unusual Properties and Is Expressed in the Brain
Xiang et al.
J. Biol. Chem. 2005;280:11608-11614.
ABSTRACT
| FULL TEXT
Reversal of Parkinsonism and Portosystemic Encephalopathy Following Embolization of a Congenital Intrahepatic Venous Shunt: Brain MR Imaging and 1H Spectroscopic Findings
da Rocha et al.
Am. J. Neuroradiol. 2004;25:1247-1250.
ABSTRACT
| FULL TEXT
|